Imunon (IMNN) Cash from Operations (2010 - 2026)
Imunon's (IMNN) quarterly Cash from Operations came in at 3985176.0 in Q1 2026, down 39.98% YoY from 6639257.24 in Q1 2025, and down 8.97% on a QoQ basis from 3657101.0 in Q4 2025.
Imunon (IMNN) Cash from Operations (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Cash from Operations data on file, last reported at 3985176.0 in Q1 2026.
- Quarterly Cash from Operations fell 39.98% year-over-year to 3985176.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15034749.0 (up 5.01% YoY) and the FY2025 annual result came in at 13896624.0, up 26.3% from the prior year.
- Cash from Operations declined to 3985176.0 in Q1 2026, from 3657101.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2847051.0 in Q1 2025 to a low of 7976520.0 in Q1 2022.
- A 5-year average of 4638577.24 and a median of 4441083.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 109.47% — and 2025, when it jumped 51.53%.
- Tracing IMNN's Cash from Operations over 5 years: stood at 5007558.0 in 2022, then increased by 24.67% to 3772265.0 in 2023, then decreased by 17.2% to 4420984.0 in 2024, then gained by 17.28% to 3657101.0 in 2025, then slipped by 8.97% to 3985176.0 in 2026.
- The last three Cash from Operations figures came in at 3985176.0 (Q1 2026), 3657101.0 (Q4 2025), and 4441083.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 728.46 Mn |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | -3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.01 Mn |
| Jun 30, 2026 | -3.01 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Dec 31, 2025 | -3.66 Mn |
| Dec 31, 2025 | -3.66 Mn |
| Sep 30, 2025 | -4.44 Mn |
| Sep 30, 2025 | -4.44 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Jun 30, 2025 | -2.95 Mn |
| Mar 31, 2025 | -2.85 Mn |
| Mar 31, 2025 | -2.85 Mn |
| Dec 31, 2024 | -4.42 Mn |
| Dec 31, 2024 | -4.42 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.50 Mn |
| Jun 30, 2024 | -4.50 Mn |
| Mar 31, 2024 | -5.87 Mn |
| Mar 31, 2024 | -5.87 Mn |